Publication & Citation Trends
Publications
0 total
Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study OA
Cited by 12
Semantic Scholar
Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study OA
Cited by 39
Semantic Scholar
Analyse comparative en sous-groupe de umeclidinium/vilanterol vs. tiotropium chez des patients BPCO
Cited by 0
Semantic Scholar
Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial OA
Cited by 31
Semantic Scholar
Prevention of deteriorations in COPD on stepping up from tiotropium to umeclidinium/vilanterol
Cited by 0
Semantic Scholar
Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study. OA
Cited by 7
Semantic Scholar
Once-daily umeclidinium/vilanterol 125/25 mcg in COPD: a randomized, controlled study.
Cited by 166
Semantic Scholar
Dose response of umeclidinium administered once or twice daily in patients with COPD: A pooled analysis of two randomized, double‐blind, placebo‐controlled studies
Cited by 12
Semantic Scholar
Research Topics
Chronic Obstructive Pulmonary Disease (COPD) Research
(15)
Asthma and respiratory diseases
(13)
Receptor Mechanisms and Signaling
(6)
Respiratory and Cough-Related Research
(6)
Pharmacological Effects and Assays
(4)
Affiliations
University of North Carolina at Chapel Hill
Albert Einstein College of Medicine
Research Triangle Park Foundation
Yeshiva University
University of Florida